ILF2 and hepatocellular carcinoma: Although the specific molecular mechanisms of these two genes have not yet been fully elucidated, existing evidence suggests that Ilf2 may enhance the proliferative capacity of HCC cells by regulating cell cycle-related gene networks, whereas Vars may affect cancer cell survival and proliferation through lactylation-mediated translational regulation.